These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 19284806)
1. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. Oba Y Am J Manag Care; 2009 Feb; 15(2):97-104. PubMed ID: 19284806 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD. Oba Y Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD. Earnshaw SR; Wilson MR; Dalal AA; Chambers MG; Jhingran P; Stanford R; Mapel DW Respir Med; 2009 Jan; 103(1):12-21. PubMed ID: 19010652 [TBL] [Abstract][Full Text] [Related]
4. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement. Dong H; Buxton M Int J Technol Assess Health Care; 2006; 22(2):191-202. PubMed ID: 16571195 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of group psychotherapy for depression in Uganda. Siskind D; Baingana F; Kim J J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. Sin DD; Golmohammadi K; Jacobs P Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. Hass B; Lungershausen J; Hertel N; Poulsen Nautrup B; Kotowa W; Liedgens H Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150 [TBL] [Abstract][Full Text] [Related]
9. Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs. Clini EM; Magni G; Crisafulli E; Viaggi S; Ambrosino N Respiration; 2009; 77(1):44-50. PubMed ID: 18417954 [TBL] [Abstract][Full Text] [Related]
10. Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia. Breitscheidel L J Med Econ; 2008; 11(4):571-84. PubMed ID: 19450068 [TBL] [Abstract][Full Text] [Related]
11. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study. Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of health care costs for patients using home oxygen therapy or those in waiting lists]. Maquilón C; Chiong H; Bello S; Naranjo C; Lira P; Díaz M Rev Med Chil; 2001 Dec; 129(12):1395-403. PubMed ID: 12080877 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. Xie F; Luo N; Blackhouse G; Goeree R; Lee HP Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain. Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582 [TBL] [Abstract][Full Text] [Related]
15. A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems. Mapel DW; Robinson SB; Lydick E Respir Care; 2008 Sep; 53(9):1169-75. PubMed ID: 18718034 [TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Najafzadeh M; Marra CA; Sadatsafavi M; Aaron SD; Sullivan SD; Vandemheen KL; Jones PW; Fitzgerald JM Thorax; 2008 Nov; 63(11):962-7. PubMed ID: 18621985 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada. Wagner M; Goetghebeur M; Merikle E; Pandya A; Chu P; Taylor DC Can J Clin Pharmacol; 2009; 16(2):e331-45. PubMed ID: 19531812 [TBL] [Abstract][Full Text] [Related]